MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Leveraging MRI and machine-learning for early detection of cognitive impairment in Parkinson’s disease

    L. Saadatpour, A. Vijayakumari, B. Walter, H. Fernandez (Cleveland, USA)

    Objective: To develop a machine learning model using MRI data that predicts the likelihood of cognitive impairment in newly diagnosed patients with Parkinson's disease (PD).…
  • 2023 International Congress

    Introduction of a Parkinson’s Disease Virtual Ward Round

    K. Ramsay (Sutton-in-Ashfield, United Kingdom)

    Objective: To introduce an electronic alert when people with Parkinson’s disease (PwP) are admitted to Sherwood Forest Hospitals NHS Trust (SFH). Background: PwP are more…
  • 2023 International Congress

    Specific Parkinson’s disease phenotype in patients with long term PTSP

    I. šarac, H. šarac, N. Henigsberg, F. Borovečki, Z. Krešić, I. Ivek, T. Sukobljević (Zagreb, Croatia)

    Objective: to describe possibly specific clinical phenotype of PD patients who suffered from long-term postraumatic-stress-disorders (PTSD Background: There is enough evidence about the relationship between…
  • 2023 International Congress

    Pharmacological combinations in early stages of Parkinson’s disease and association with motor complications

    A. Lanore, E. Januel, N. Bertille, P. Menon, Y. Rajasegaram, S. Carvalho, LL. Mariani, M. Fabbri, O. Rascol, F. Tubach, Y. de Rycke, JC. Corvol (Paris, France)

    Objective: To describe the different combinations of dopaminergic drugs at the early stage of Parkinson’s disease (PD) in a real-life cohort, and to determine their…
  • 2023 International Congress

    Effects and neural mechanisms of training involving rhythmic auditory stimulation on upper-limb movements in patients with Parkinson’s disease

    W. Fan, K. Fong, S. Wang (Hong Kong, China)

    Objective: This study is to examine effects and neural mechanisms of training involving rhythmic auditory stimulation on upper-limb movements in patients with Parkinson’s disease (PD).…
  • 2023 International Congress

    Apomorphine sublingual film for OFF episodes in PD: Impact on orthostatic hypotension during dose-optimization

    W. Jost, M. Coelho, M. Fonseca, G. Castilla-Fernández, D. Magalhães, CK. Denecke Muhr (Wolfach, Germany)

    Objective: To assess the occurrence of orthostatic hypotension (OH) during apomorphine sublingual film (SL-APO) dose-optimization in patients with Parkinson’s disease (PwPD). Background: SL-APO has been…
  • 2023 International Congress

    Risk of Parkinson’s disease in spinal cord injury: a nationwide cohort study in south Korea

    JH. Ahn, KD. Han, H. Choi, W. Jung, JW. Cho, J. Youn, DW. Shin (Seoul, Republic of Korea)

    Objective: In the present population-based study, we investigated the association of PD with SCI according to the severity of disability and injured spinal cord level,…
  • 2023 International Congress

    The effects of one session of dry needling on vital capacity in people with Parkinson’s Disease

    A. Tahara, A. Gastaldi, A. Chinaglia, R. Monteiro, V. Tumas, P. Santiago (Ribeirão preto, Brazil)

    Objective: The present study aimed to explore the effects of a single session of bilateral DN to the trapezius muscles trigger points on chest expansion and…
  • 2023 International Congress

    Tremor characteristics differentially respond to levodopa and subthalamic nucleus deep brain stimulation in Parkinson’s disease

    T. Wirth, F. Ferreira, N. Vijiaratnam, C. Girges, A. Pakzad, A. Roquemaurel, O. Sinani, J. Hyam, M. Hariz, L. Zrinzo, H. Akram, P. Limousin, T. Foltynie (Strasbourg, France)

    Objective: To identify factors predictive of responsiveness of tremor to levodopa and STN-DBS. Background: Tremor in Parkinson’s disease (PD) is phenotypically variable and has an…
  • 2023 International Congress

    A cross-sectional study of telemedicine use during the COVID-19 pandemic in people with Parkinson’s disease

    A. Patel, R. Schuldt, D. Boudreau, N. Win, B. Cobb, M. Mcginley (South San Francisco, USA)

    Objective: To evaluate telemedicine (TM) use and access patterns during the COVID-19 pandemic in people with Parkinson’s disease (pwPD). Background: pwPD may experience difficulty accessing…
  • « Previous Page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley